Ethyl 2-(3-Cyanophenyl)-1,4-dimethyl-1H-imidazole-5-carboxylate

ID: ALA4777954

PubChem CID: 162644393

Max Phase: Preclinical

Molecular Formula: C15H15N3O2

Molecular Weight: 269.30

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(C)nc(-c2cccc(C#N)c2)n1C

Standard InChI:  InChI=1S/C15H15N3O2/c1-4-20-15(19)13-10(2)17-14(18(13)3)12-7-5-6-11(8-12)9-16/h5-8H,4H2,1-3H3

Standard InChI Key:  PVOSKUQTFGBOGP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   14.3861  -18.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3850  -19.1238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0930  -19.5327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8027  -19.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7998  -18.3006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0912  -17.8954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5038  -17.8910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2516  -18.2206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7961  -17.6112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3848  -16.9050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5862  -17.0780    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6091  -17.6936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7143  -16.1572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5267  -16.0686    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2314  -15.4979    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.8562  -15.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6686  -15.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0957  -20.3459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0955  -21.1631    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9768  -16.5335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
  5  7  1  0
  9 12  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 18 19  3  0
  3 18  1  0
 11 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777954

    ---

Associated Targets(non-human)

Plasma (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 269.30Molecular Weight (Monoisotopic): 269.1164AlogP: 2.44#Rotatable Bonds: 3
Polar Surface Area: 67.91Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.58CX LogP: 2.37CX LogD: 2.37
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.80Np Likeness Score: -1.65

References

1. Lei Y,Zhang B,Liu D,Zhao J,Dai X,Gao J,Mao Q,Feng Y,Zhao J,Lin F,Duan Y,Zhang Y,Bao Z,Yang Y,Mou Y,Wang S.  (2020)  Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y and P2Y as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor.,  63  (24): [PMID:33307675] [10.1021/acs.jmedchem.0c01524]

Source